The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...

In an era where health and wellness are prioritized more than ever, the quest for effective natural remedies has led many to ...

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

Dec. 2, 2024 — Alcohol's ability to increase people's pain threshold is one reason that drinking also leads to more aggressive behavior, a new study suggests. Researchers found that the less ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...